Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 6/20 | 0.62 |
| ▸ | HTR2B | P41595 | 1/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30576428 | 1.00 | TYR (0.62) | TYRHTR2BALOX5MEN1MAPT | |
| SCHEMBL30576429 | 0.84 | ALOX5 (0.53) | TYRALOX5MEN1MAPTHTT | |
| SCHEMBL1846967 | 0.84 | ALOX5 (0.53) | TYRALOX5MEN1MAPTHTT | |
| SCHEMBL21154074 | 0.80 | HTR2B (0.49) | HTR2BMEN1KMT2ACYP3A4ALOX15 | |
| SCHEMBL1397158 | 0.79 | TYR (1.00) | TYRALOX5MEN1MAPTHTT | |
| SCHEMBL8146532 | 0.74 | ALDH1A1 (0.54) | HTR2BALOX5MEN1MAPTKMT2A | |
| SCHEMBL29975956 | 0.74 | LMNA (0.41) | HTR2BALOX5MEN1MAPTHTT | |
| SCHEMBL6732302 | 0.74 | LMNA (0.41) | HTR2BALOX5MEN1MAPTHTT | |
| SCHEMBL24201406 | 0.74 | TYR (0.78) | TYRALOX5MEN1MAPTHTT | |
| SCHEMBL2902317 | 0.71 | TYR (0.74) | TYRALOX5MEN1MAPTHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4046619-A1 | SERIES OF SKIN-WHITENING (LIGHTENING) COMPOUNDS | Unigen, Inc. (US) | 2022-08-24 | — | — | EP | claimed |
| US-8658838-B2 | Series of skin whitening (lightening) compounds | UNIGEN, INC. (US) | 2014-02-25 | — | — | US | claimed |
| US-20130209383-A1 | SERIES OF SKIN WHITENING (LIGHTENING) COMPOUNDS | UNIGEN, INC. (US) | 2013-08-15 | — | — | US | claimed |
| US-8362305-B2 | Series of skin whitening (lightening) compounds | UNIGEN, INC. (US) | 2013-01-29 | — | — | US | claimed |
| EP-2323612-A1 | SERIES OF SKIN-WHITENING (LIGHTENING) COMPOUNDS | Unigen, Inc. (US) | 2011-05-25 | — | — | EP | claimed |
| WO-2010011630-A1 | SERIES OF SKIN-WHITENING (LIGHTENING) COMPOUNDS | UNIGEN PHARMACEUTICALS, INC. (US) | 2010-01-28 | — | — | WO | claimed |
| US-20100016347-A1 | SERIES OF SKIN WHITENING (LIGHTENING) COMPOUNDS | UNIGEN PHARMACEUTICALS, INC. (US) | 2010-01-21 | — | — | US | claimed |
| US-12227472-B2 | Series of skin-whitening (lightening) compounds | UNIGEN, INC. (US) | 2025-02-18 | — | — | US | disclosed |
| US-20230399282-A1 | Series of Skin-Whitening (Lightening) Compounds | UNIGEN, INC. (US) | 2023-12-14 | — | — | US | disclosed |
| US-20230399282-A1 | Series of Skin-Whitening (Lightening) Compounds | UNIGEN, INC. (US) | 2023-12-14 | — | — | US | disclosed |
| US-20230399282-A1 | Series of Skin-Whitening (Lightening) Compounds | UNIGEN, INC. (US) | 2023-12-14 | — | — | US | disclosed |
| US-11739040-B2 | Series of skin-whitening (lightening) compounds | UNIGEN, INC. (US) | 2023-08-29 | — | — | US | disclosed |
| US-11739040-B2 | Series of skin-whitening (lightening) compounds | UNIGEN, INC. (US) | 2023-08-29 | — | — | US | disclosed |
| US-8362305-B2 | Series of skin whitening (lightening) compounds | UNIGEN, INC. (US) | 2013-01-29 | — | — | US | disclosed |
| US-8362305-B2 | Series of skin whitening (lightening) compounds | UNIGEN, INC. (US) | 2013-01-29 | — | — | US | disclosed |
| EP-2323612-A1 | SERIES OF SKIN-WHITENING (LIGHTENING) COMPOUNDS | Unigen, Inc. (US) | 2011-05-25 | — | — | EP | disclosed |
| WO-2010011630-A1 | SERIES OF SKIN-WHITENING (LIGHTENING) COMPOUNDS | UNIGEN PHARMACEUTICALS, INC. (US) | 2010-01-28 | — | — | WO | disclosed |
| WO-2010011630-A1 | SERIES OF SKIN-WHITENING (LIGHTENING) COMPOUNDS | UNIGEN PHARMACEUTICALS, INC. (US) | 2010-01-28 | — | — | WO | disclosed |
| US-20100016347-A1 | SERIES OF SKIN WHITENING (LIGHTENING) COMPOUNDS | UNIGEN PHARMACEUTICALS, INC. (US) | 2010-01-21 | — | — | US | disclosed |
| US-20100016347-A1 | SERIES OF SKIN WHITENING (LIGHTENING) COMPOUNDS | UNIGEN PHARMACEUTICALS, INC. (US) | 2010-01-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11739040-B2 | Series of skin-whitening (lightening) compounds | TYR, TH, MAOB | TYR 1/4885HTR2B 368/4885ALOX5 301/4885 |
| US-20230399282-A1 | Series of Skin-Whitening (Lightening) Compounds | TYR, TH, MAOB | TYR 1/4885HTR2B 368/4885ALOX5 301/4885 |
| US-20130209383-A1 | SERIES OF SKIN WHITENING (LIGHTENING) COMPOUNDS | TYR, MAOB, TH | TYR 1/4885HTR2B 410/4885ALOX5 287/4885 |
| US-20100016347-A1 | SERIES OF SKIN WHITENING (LIGHTENING) COMPOUNDS | TYR, MAOB, TH | TYR 1/4885HTR2B 410/4885ALOX5 287/4885 |
| US-12227472-B2 | Series of skin-whitening (lightening) compounds | TYR, TH, MAOB | TYR 1/4885HTR2B 368/4885ALOX5 301/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.